Legal Cannabis and CBD-Based Products Projected to Gain …

NEW YORK, June 28, 2017 /PRNewswire/ —

According to a recent report by New Frontier Data, the Viridian Cannabis Stock Index gained 236.1% in 2016, or outperforming such mainstream indexes as the Russell 2000 (up 19.5%), the Dow Jones Industrial Average (up 13.4%), the SP 500 (up 9.5%), and the Nasdaq composite (up 7.5%). Businesses that touch the plant and in ancillary sector, helps to show the data growth in 2016 of underlying sectors in the cannabis markets. New Frontier Data also indicates that in 2017, medical cannabis sales are forecast to grow to $5.3 billion, or accounting for 67% of total cannabis sales. By 2025, medical sales in currently legal states are forecast to grow to $13.2 billion, at this point medical sales will account for 55% of all sales. Comparatively, adult-use sales in 2017 are forecast to reach $2.6 billion, or rising to $10.9 billion by 2025., Inc. (OTC: CIIX), Cannabis Sativa, Inc. (OTC: CBDS),

... read more at: